galecto biotech biotechnology company develops small molecules treatment severe diseases including cancer inflammation company founded leading galectin scientists biotech executives sweden united kingdom denmark company today incorporated us operating headquarters copenhagen denmark company builds years research centering role use modulators proteins treat fibrosisrelated diseases cancer combined strong patent estate assets give galecto unique therapeutic platform galectos lead product candidate inhaled inhibitor developed treatment severe fibrotic lung diseases idiopathic pulmonary fibrosis ipf high unmet medical companys portfolio also includes orally delivered inhibitor treatment systemic fibrotic diseases including liver cirrhosis inhibitor lysyl oxidase like enzyme directly involved formation fibrosis part companys plan develop myelofibrosis httpsenwikipediaorgwikigalectobiotech